Fifth Third Becomes First Bank to Offer Free Wills to All Customers
CINCINNATI--(BUSINESS WIRE)--Fifth Third (NASDAQ: FITB) today announced a first-of-its-kind initiative to offer free wills to every customer, through an exclusive partnership with Trust & Will, the leading digital estate planning platform in the U.S.
Starting today, millions of Fifth Third customers can access a secure, guided online experience to create a state-specific, attorney approved will – at no cost and in less than one hour. This experience is designed to be simple and stress-free, ensuring peace of mind and a streamlined legal process for more American families during what can be a time of great emotional turmoil.
This pioneering offer from Fifth Third and Trust & Will seeks to addresses a significant gap in estate planning in the U.S. According to Trust & Will's 2025 Estate Planning Report, which surveyed 10,000 Americans aged 18 and over, 83% of Americans think a will is important, and yet only 31% have one in place. This lack of preparedness isn't evenly distributed. Older generations, wealthier households, and men tend to be more prepared, while younger adults, lower-income individuals, and women lag behind.
'At Fifth Third, we are leading the industry with digital solutions that solve everyday banking needs,' said Ben Hoffman, chief strategy officer and head of consumer products at Fifth Third. 'First, we focused on getting customers paid as early as possible, which then streamlined how they paid others. In response to evolving threats of scams and fraud, we reinforced security protections to better protect customers identity and money. Now, we're thrilled to address another gap in financial planning with this novel partnership, securing our customers' legacies for generations to come.'
For many families, not having an estate plan can result in significant financial strain and stress. Without a will, families may struggle to access critical funds needed for funeral expenses, rent, or everyday bills. By offering free wills to all families, Fifth Third Bank and Trust & Will proactively address these concerns, ensuring families of all income levels have access to modern tools to secure their legacies and protect what matters most.
'We believe every family deserves peace of mind,' said Cody Barbo, CEO of Trust & Will. 'Our mission is to make estate planning accessible to all, and this partnership brings us one step closer to that goal.'
Fifth Third customers can learn more about Trust & Will and get started at 53.com/TrustandWill.
About Fifth Third
Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies ® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust.
Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ ® Global Select Market under the symbol "FITB." Investor information and press releases can be viewed at www.53.com. Deposit and credit products provided by Fifth Third Bank, National Association. Member FDIC.
About Trust & Will
Founded in 2017, Trust & Will is the leading digital estate planning platform in the U.S., trusted by over one million individuals and families. Our simple, secure, and attorney-approved online solutions help Americans easily create wills, trusts, healthcare directives, and other essential estate planning documents tailored to state-specific laws. With a focus on easy access and a guided experience, we're transforming how families plan for the future and protect their legacies.
Our platform supports 17,000+ financial advisors, along with 150+ enterprise partners and financial institutions — including AARP, Fifth Third Bank, LPL Financial, UBS, and USAA. We empower professionals to integrate estate planning into their client services, enabling multi-generational wealth planning. With more than one million users and $100+ billion in self-reported estate assets, Trust & Will is redefining estate planning as a relationship-deepening driver of financial wellness.
Recognized for innovation and leadership, Trust & Will has earned spots on the CNBC Disruptor 50, Inc. 5000, and Deloitte Technology Fast 500™ lists.
Learn more at trustandwill.com.
Category: Other
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Fortrea Names Anshul Thakral Chief Executive Officer
Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board DURHAM, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the 'Company'), a leading global contract research organization (CRO), today announced that Fortrea's Board of Directors (the 'Board') named Anshul Thakral as Fortrea's CEO, effective August 4, 2025. He was also appointed to serve as a director on the Company's Board, effective as of that date. Thakral succeeds Interim CEO, Peter M. Neupert, who will remain as chairman of the board. Thakral brings more than 20 years of experience in life sciences as an executive and commercial leader, advisor and entrepreneur. He will focus on executing the Company's transformation plan and sharpening Fortrea's focus on profitable growth. Further, he will oversee additional value creation efforts for customers, employees and shareholders. 'Anshul is an exceptional leader with extensive life sciences experience, deep familiarity with the CRO industry, a commitment to innovation and a proven record of building companies and growing revenue,' said Neupert. 'His strong business development capabilities, commercial insights and relentless focus on customer engagement make him ideally suited to lead Fortrea. Further, he also shares the Company's commitment to modernizing the clinical trials process and combining the best talent, science and technology to effectively and efficiently respond to changing customer and patient needs. We are delighted to welcome Anshul to Fortrea as we seek to capitalize on the significant growth opportunities we see ahead and meet our customers' needs.' 'Since its founding, the Fortrea team has earned a strong reputation for leading with science and creating a differentiated customer experience,' said Thakral. 'I share the team's passion for customers and the patients they serve, and I'm honored to take the reins at this pivotal moment. It is an exciting opportunity to lead the organization as it continues to deliver flexible and agile drug development solutions that accelerate the delivery of life-changing treatments to patients. I'm confident this company can execute on its patient and customer-focused mission while delivering profitable growth, which ultimately delivers value for shareholders.' About Anshul Thakral Thakral joins Fortrea from Launch Therapeutics, a company he co-founded at which he served as CEO. Previously, he held several executive leadership roles at PPD, a leading CRO, including chief commercial officer and executive vice president of Peri- and Post-Approval Services. He led PPD Biotech, which contributed to PPD's growth. Prior to PPD, Thakral ran the global life sciences business unit at Gerson Lehrman Group and served as an Associate Principal at McKinsey & Company in the healthcare practice. He currently serves on the board of directors of TriNetX, Saama Technologies and Orsini Specialty Pharmacy. He earned his B.S. and M.S.E. in Biomedical Engineering from Johns Hopkins University and his MBA from the Wharton School at the University of Pennsylvania. About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on LinkedIn and X (formerly Twitter). Cautionary Statement Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, the Company's growth opportunities. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as 'guidance,' 'expect,' 'assume,' 'anticipate,' 'intend,' 'plan,' 'forecast,' 'believe,' 'seek,' 'see,' 'will,' 'would,' 'target,' similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from the Company's expectations due to a number of factors, including, but not limited to, the following: the Company's ability to successfully implement its business strategies and execute its long-term value creation strategy; risks and expenses associated with the Company's international operations, tariff policies, trade sanctions and other trade restrictions and currency fluctuations; the Company's customer or therapeutic area concentrations; any further deterioration in the macroeconomic environment or further changes in government regulations and funding, which could lead to defaults or cancellations by the Company's customers; the risk that the Company's backlog and net new business may not be indicative of the Company's future revenues and that the Company might not realize all of the anticipated future revenue reflected in the Company's backlog; the Company's ability to generate sufficient net new business awards, or the possibility that net new business awards are delayed, terminated, reduced in scope, or fail to go to contract; if the Company underprices its contracts, overruns its cost estimates, or fails to receive approval for, or experiences delays in documentation of change orders; and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company's business, see the 'Risk Factors' Section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission (the "SEC"), as such factors may be amended or updated from time to time in the Company's subsequent periodic and other filings with the SEC, which are accessible on the SEC's website at These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in the Company's filings with the SEC. All forward-looking statements are made only as of the date of this release and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Contacts: Hima Inguva (Investors) – 877-495-0816, Sue Zaranek (Media) – 919-943-5422, media@ Kate Dillon (Media) – 646-818-9115, kdillon@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
Why Trump Is Losing His Trade War
The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. Donald Trump's trade war is fast turning into a fiasco. When the president started the war, Team Trump advertised it as certain to be fast, easy, and cheap. Trump would impose tariffs. The world would yield to his will. The tariffs would do everything at once. They would protect U.S. industry from foreign competition without raising prices, and generate vast revenues that would finance other tax cuts. Americans could eat their cake, continue to have the cake, and trade the same cake for pie—all at the same time. 'There's not going to be any pain for American workers,' Trump's press secretary, Karoline Leavitt, vowed in April. The advertising rapidly proved false. The U.S. economy is slowing because of the Trump tariffs; China's is thriving in spite of them. Team Trump falsely promotes vague five-page outlines with alienated former allies as big deals; China is successfully wooing some of its former rivals, such as Vietnam. America's standing in the world is measurably sinking; China's is measurably rising. Courts are ruling that Trump's tariffs are illegal; public opinion mistrusts the tariffs, regarding them as expensive and unproductive. The promise of huge flows of painless money from tariff revenues is evanescing as the fantasy it always was. Oh, and the country's largest chain of Halloween retailers canceled its traditional summer grand opening because of Trump-caused supply disruptions. What comes next, as things go wrong? Trump's first instinct is to blame the targets of his economic aggression for not cooperating with his wishes. On May 30, Trump accused China of violating an imaginary agreement with him. On June 4, he complained that Xi Jinping was 'extremely hard to make a deal with.' But Trump seldom chooses to quarrel with foreign dictators, saying in the same breath, 'I like President Xi of China, always have, and always will.' Today, in all-caps emphasis, Trump announced that a deal had been done, declaring that his 'RELATIONSHIP IS EXCELLENT' with the Chinese president-for-life. The lack of details in the announcement strongly suggests that Trump yielded more and gained less than his publicity apparatus wants Americans to believe. That's because, in reality, Trump's global trade war has always been subordinate to his domestic culture war. Trump much prefers to vent his rage against enemies within. Get ready for him to blame the failure of his trade war on fellow Americans who did not support him enough. The Trump tariffs will be ballyhooed as an act of patriotism, a necessary sacrifice to be laid on the altar of the nation. One of Trump's television talkers reminded viewers that Americans melted down their pots and pans to win the Second World War. If the president needs to ration dolls and colored pencils, how dare any true American raise a contrary voice? The coming call for national solidarity with Trump's Great Patriotic War against imported Halloween costumes deserves all the scoffing it will get and more. Trump ordered the nation into economic warfare. He did not do any of the things necessary to create any hope of success in that war. The impending defeat is his personal doing, entirely his own fault. [Jonathan Chait: The good news about Trump's tariffs] Recall the classic Norm Macdonald bit in which the comedian marvels that in the 20th century, Germany decided to go to war with 'the world,' twice. That was meant as a joke. Trump adopted it as his actual strategy. Trump's rationalizers invoke anxiety about China as his justification. Yes, China numbered among the targets of Trump's 'Liberation Day' tariffs. But so did Australia. So did Brazil. So did Canada. So did Denmark. So did Egypt. And on and on, through the whole alphabet of American allies and trading partners. The United States is by far the planet's strongest national economy, producing slightly more than one-quarter of the planet's goods and services. Including its historic and recent partners, the United States could potentially lead a group of nations sufficiently influential to write economic rules that everybody would need to take into account. That fact underpinned the Trans-Pacific Partnership concept of the Obama years: Form a large-enough and attractive-enough club, and China will have no choice but to comply with the founding members' terms. Trump's alternative concept is for a quarter of the world economy to cut itself off from the other three-quarters, and then wait for the three-quarters to beg for mercy from the one-quarter. Unsurprisingly, that concept is fast proving a stinker. But suppose the president sincerely believed that the U.S. had no choice: The one-quarter must fight the three-quarters as a matter of national survival, or 'liberation,' from the tyranny of foreign goods and services, foreign fruits and vegetables. Crazy, but suppose he did. What would follow? A rational president would grasp that a U.S. economic war against the rest of the world would be a big, protracted, and painful undertaking. Such an enormous commitment would require democratic consent from a large majority of the public, all the more so because the United States is starting the war itself. Trump's trade conflict is very much a war of choice. The president must explain why he chose it. A rational president determined to fight an economic war would try to mobilize broad support from the public and from Congress. He would seek allies in Congress, and not only from his own party. He might, for example, compromise on some of his other goals. If he also wanted to tighten immigration at the same time as waging a global trade war, or to roll back DEI programs, or to cut taxes for the wealthy, or to relax anti-corruption measures, or to pardon the crimes of his violent supporters, or to plan any other ambitious but divisive project, he might think twice about pursuing them. You can't ask your opponents to pay more and do without if you won't forgo even a scrap of your partisan agenda. You can ask anyway, but don't be shocked when they answer with a Bronx cheer. That president would also lead from the front. A president seeking to inspire Americans to endure hardship for the greater good would certainly not throw himself a multimillion-dollar birthday parade at public expense. He would not accept lavish gifts from foreign governments, would not operate a pay-for-access business that collected billions of dollars for himself and his family from undisclosed favor-seekers. While asking other Americans to accept less, he would not brazenly help himself to more. He certainly would not troll, insult, and demean those who may not have voted for him, but whose cooperation he needs now. This president has, of course, done the most egregious version of every item above. His economic war is adjunct to his partisan culture war. He did not seek broad support. He gleefully offends and alienates everyone outside his base. Which works for him as long as times are prosperous, as they were in the first three years of his first administration. Allow things to get tough, though, and it's a different story. Trump cannot ask for patience and trust, because at least half the country has unalterably judged him as untrustworthy and out only for himself. [David Frum: The ultimate bait and switch of Trump's tariffs] Trump bet his presidency on the theory that trade wars are 'good and easy to win,' as he posted during his first term. His second-term trade war, however, is proving not so easy, and not so good, either. He is fighting it alone, without global allies or domestic consent, because that's his nature. It's now also his problem. In the 1983 movie WarGames, a computer thinks its way through dozens of terrifying nuclear scenarios and concludes: 'The only winning move is not to play.' In other words, the only safe way to conduct a nuclear exchange is never to have one. The same could be said of trade wars, at least when fought by one nation, however big and rich, against all the others, all at once. Trump decided he did not care about Americans' support for his economic war. He did not ask for their backing. He did not make any effort to win it. He willfully alienated at least half of the public. Now that he's losing, his supporters want to scold the country because it rejects the whole misbegotten project as stupid and doomed. Don't listen to their reproaches. This is Trump's war, and his alone. The only way to win now is to end Trump's trade war as rapidly as possible. And then end the excessive, unilateral trade powers of a corrupt president who blundered into a pointless and doomed conflict without justification, plan, or consent. Article originally published at The Atlantic
Yahoo
11 minutes ago
- Yahoo
CSX Announces Ratification of Labor Deal with Locomotive Engineers
JACKSONVILLE, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) today announced that employees represented by the Brotherhood of Locomotive Engineers and Trainmen (BLET) have voted to ratify the five-year collective bargaining agreement covering approximately 3,400 locomotive engineers. This is the first ratification reached by a Class I freight railroad with BLET. 'The ratified agreement demonstrates the value of our partnership with BLET, our CSX General Chairmen, and our shared commitment to improving the day-to-day experience for our locomotive engineers,' said Joe Hinrichs, President and CEO of CSX. 'I want to thank our engineers for their unwavering dedication to our customers and the communities in which we live and work. This is a significant milestone for our people and the future of our railroad.' The agreement mirrors the general wage increases, and health and welfare improvements from CSX's agreements with 13 other unions. Locomotive engineers make up approximately 20 percent of CSX's frontline workforce. To date, nearly 75 percent of CSX unionized workers are now covered by new agreements reached within the last 10 months. The only remaining major workgroup at CSX not covered by new agreements or a tentative agreement are trainmen/conductors represented by SMART-TD. CSX is currently engaged in bargaining with SMART-TD to consolidate separate territories, workforces, and execute a single-system collective agreement. About CSX CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural and consumer products. For nearly 200 years, CSX has played a critical role in the nation's economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation's population resides. It also links more than 240 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike. More information about CSX Corporation and its subsidiaries is available at Like us on Facebook ( and follow us on X, formerly known as Twitter ( Contact: Matthew Korn, CFA, Investor Relations904-366-4515 Bryan Tucker, Corporate Communications 855-955-6397Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
